Abstract:Gadolinium (Gd3+) based dendrimers with precise and tunable nanoscopic sizes are excellent candidates as magnetic resonance imaging (MRI) contrast agents. Control of agents’ sensitivity, biosafety and functionality is key to the successful applications. We report the synthesis of Gd(III)-based peptide dendrimers possessing highly controlled and precise structures, and their potential applications as MRI contrast agents. These agents have no obvious cytotoxicity as verified by in vitro studies. One of the dendrimer formulations with mPEG modification showed a 9-fold increase in T1 relaxivity to 39.2 Gd(III) mM−1 s−1 comparing to Gd-DTPA. In vivo studies have shown that the mPEGylated Gd(III)-based dendrimer provided much higher signal intensity enhancement (SI) in mouse kidney, especially at 60 min post-injection, with 54.8% relatively enhanced SI. The accumulations of mPEGylated dendrimer in mouse liver and kidney were confirmed through measurement of gadolinium by inductively coupled plasma atomic emission spectroscopy (ICP-AES). Meanwhile, mPEGylated dendrimer showed much higher Gd(III) concentration in blood with 38 μg Gd(III)/g blood at 1 h post-injection comparing to other dendrimer formulations. These findings provide an attractive alternative strategy to the design of multifunctional gadolinium-based dendrimers with controlled structures, and open up possibilities of using the Gd(III)-based peptide dendrimers as MRI probes.

Evaluation of Dendritic Gadolinium Complexes as MRI Contrast Agents

The Development of Dendritic Gd-Dtpa Complexes for Mri Contrast Agents

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Synthesis and preliminary evaluation of gadolinium complexes containing sulfonamide groups as potential MRI contrast agents

Development of Magnetic Resonance Imaging Contrast Agents with PAMAM Dendrimer Cores

Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.

Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents

A Dendritic Supramolecular Complex as Uniform Hybrid Micelle with Dual Structure for Bimodal In Vivo Imaging.

A Dendritic Supramolecular Complex As Uniform Hybrid Micelle with Dual Structure for Bimodal in Vivo Imaging

Synthesis and Properties of a Biodegradable Dendritic Magnetic Resonance Imaging Contrast Agent

Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application

Biocompatible Supramolecular Dendrimers Bearing a Gadolinium-Substituted Polyanionic Core for MRI Contrast Agents

Synthesis and Evaluation of Aromatic Dtpa-Bis(Amide) Gadolinium Complexes As Magnetic Resonance Imaging Contrast Agents

Synthesis and Evaluation of Neutral Gd(III), Mn(II) Complexes from DTPA-Bisamide Derivative As Potential MRI Contrast Agents

Synthesis and evaluation of Gd-DTPA-labeled arabinogalactans as potential MRI contrast agents

Comparison Between Gd-Dtpa and Several Bisamide Derivatives As Potential Mri Contrast Agents

The gadolinium complexes with polyoxometalates as potential MRI contrast agents.

A Biocompatible Gadolinium-Based Amino Acid Copolymer Contrast Agent for Magnetic Resonance Imaging

Multifunctional Gadolinium-Based Dendritic Macromolecules As Liver Targeting Imaging Probes.

Gadolinium-Labeled Biodegradable Dendron-Hyaluronic Acid Hybrid and Its Subsequent Application As a Safe and Efficient Magnetic Resonance Imaging Contrast Agent.

Gadolinium Complexes of Macrocyclic Diethylenetriamine-N-oxide Pentaacetic Acid-Bisamide As Highly Stable MRI Contrast Agents with High Relaxivity.